LE PREMIER ESSAI CONTRÔLÉ RANDOMISÉ DE PHASE III SUR LA THÉRAPIE DE SHUNT AURICULAIRE RESTE PROMETTEUR TEWKSBURY, Massachusetts, 23 mai 2023 /PRNewswire/ — Corvia Medical, Inc, une société dédiée à la transformation du traitement de l’insuffisance cardiaque, a annoncé aujourd’hui les…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.